Showing results (491-500 of 584) with videos related to

Sort By:
Pageof 59
JAMA Network Open|December 6, 2024
Prevalence of Life Stressors and Posttraumatic Stress Disorder Among Women in IcelandEdda Bjork Thordardottir, Huan Song, Qing Shen, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2007
Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancerSteinn Jonsson, Marileila Varella-Garcia, York E Miller, et al.
Nature Cell Biology|January 31, 2012
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activityDaniel E Foxler, Katherine S Bridge, Victoria James, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 2019
Common and Rare Sequence Variants Influencing Tumor Biomarkers in BloodSigurgeir Olafsson, Kristjan F Alexandersson, Johann G K Gizurarson, et al.
ACS Chemical Biology|October 9, 2008
DcpS as a therapeutic target for spinal muscular atrophyJasbir Singh, Michael Salcius, Shin-Wu Liu, et al.
European Journal of Human Genetics : EJHG|December 20, 2017
Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalitiesNara Sobreira, Martha Brucato, Li Zhang, et al.
Annals of Human Genetics|June 10, 2010
Evaluating differences in linkage disequilibrium between populationsBirgir Hrafnkelsson, Agnar Helgason, Gudbjorn F Jonsson, et al.
Ebiomedicine|March 25, 2026
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injuryMaria J Monte, Thi Dong-Binh Tran, Jane I Grove, et al.
Molecular Genetics and Metabolism|August 24, 2020
Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathwayBrian J Shayota, Taraka R Donti, Jing Xiao, et al.
Journal of Medicinal Chemistry|January 22, 2008
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophyJohn Thurmond, Matthew E R Butchbach, Marty Palomo, et al.
Pageof 59